Yocca Frank
Chief Scientific Officer at BTAI
- Sold, on record
- $3.9M
- Dollars the filings state
- Form 4 sales
- 11
- Latest May 20, 2026
- Form 144 notices
- 5
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BTAIBioXcel Therapeutics, Inc.Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BTAIRoutineJun 17, 2024 2024
Sold 372 shares at $1.28 ($476)
Yocca Frank, Chief Scientific Officer
10b5-1 planSold 2.7% of holdings ($18k position)13,474 shares left0.3x usual sizeFollows a Form 144Filing
- 2 Form 144 notice BTAINoticeSep 16, 2024 +91 days
Filed to sell 355 shares ($245)
Yocca Frank, Officer
10b5-1 plan0.3x usual sizeFiling
- 3 Form 4 sale BTAIRoutineSep 16, 2024 same day
Sold 355 shares at $0.69 ($245)
Yocca Frank, Chief Scientific Officer
10b5-1 planSold 2.4% of holdings ($10k position)14,203 shares left0.3x usual sizeFollows a Form 144Filing
- 4 Form 144 notice BTAINoticeOct 3, 2024 +17 days
Filed to sell 7,175 shares ($4k)
Yocca Frank, Officer
10b5-1 plan7.3x usual sizeFiling
- 5 Form 4 sale BTAIUnusualOct 3, 2024 same day
Sold 7,175 shares at $0.55 ($4k)
Yocca Frank, Chief Scientific Officer
10b5-1 planSold 20.2% of holdings ($19k position)28,278 shares left7.3x usual sizeFollows a Form 144Filing
- 6 Form 144 notice BTAINoticeDec 16, 2024 +74 days
Filed to sell 430 shares ($152)
Yocca Frank, Officer
10b5-1 planFirst sale on recordFiling
- 7 Form 4 sale BTAIRoutineDec 16, 2024 same day
Sold 430 shares at $0.35 ($152)
Yocca Frank, Chief Scientific Officer
10b5-1 planSold 1.5% of holdings ($10k position)28,931 shares leftFirst sale on recordFollows a Form 144Filing
- 8 Form 4 sale BTAIUnusualMay 20, 2026 +520 days
Sold 6,845 shares at $1.09 ($7k)
Yocca Frank, Chief Scientific Officer
10b5-1 planSold 20.7% of holdings ($36k position)26,175 shares left17.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (16)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 20, 2026 | May 22, 2026 | BTAI | Chief Scientific Officer | Form 4 sale | 6,845 | $7k | 20.7% | Unusual | SEC |
| Dec 16, 2024 | Dec 17, 2024 | BTAI | Chief Scientific Officer | Form 4 sale | 430 | $152 | 1.5% | Routine | SEC |
| Dec 16, 2024 | Dec 16, 2024 | BTAI | Officer | Form 144 notice | 430 | $152 | Notice | SEC | |
| Oct 3, 2024 | Oct 3, 2024 | BTAI | Chief Scientific Officer | Form 4 sale | 7,175 | $4k | 20.2% | Unusual | SEC |
| Oct 3, 2024 | Oct 3, 2024 | BTAI | Officer | Form 144 notice | 7,175 | $4k | Notice | SEC | |
| Sep 16, 2024 | Sep 17, 2024 | BTAI | Chief Scientific Officer | Form 4 sale | 355 | $245 | 2.4% | Routine | SEC |
| Sep 16, 2024 | Sep 16, 2024 | BTAI | Officer | Form 144 notice | 355 | $245 | Notice | SEC | |
| Jun 17, 2024 | Jun 18, 2024 | BTAI | Chief Scientific Officer | Form 4 sale | 372 | $476 | 2.7% | Routine | SEC |
| Jun 17, 2024 | Jun 17, 2024 | BTAI | Officer | Form 144 notice | 372 | $476 | Notice | SEC | |
| Apr 4, 2024 | Apr 8, 2024 | BTAI | Chief Scientific Officer | Form 4 sale | 1,067 | $3k | 7.7% | Routine | SEC |
| Apr 4, 2024 | Apr 4, 2024 | BTAI | Officer | Form 144 notice | 1,067 | $3k | Notice | SEC | |
| Mar 15, 2023 | Mar 16, 2023 | BTAI | Chief Scientific Officer | Form 4 sale | 985 | $19k | 9.4% | Plan not stated | SEC |
| Jan 20, 2023 | Jan 24, 2023 | BTAI | Chief Scientific Officer | Form 4 sale | 50,000 | $1.5M | 85.6% | Unusual | SEC |
| Mar 15, 2021 | Mar 17, 2021 | BTAI | Chief Scientific Officer | Form 4 sale | 15,000 | $728k | 20.4% | Plan not stated | SEC |
| Feb 16, 2021 | Feb 18, 2021 | BTAI | Chief Scientific Officer | Form 4 sale | 15,000 | $865k | 17.0% | Plan not stated | SEC |
| Jan 25, 2021 | Jan 27, 2021 | BTAI | Chief Scientific Officer | Form 4 sale | 15,000 | $726k | 14.5% | Plan not stated | SEC |